1. Home
  2. MRUS vs NOV Comparison

MRUS vs NOV Comparison

Compare MRUS & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • NOV
  • Stock Information
  • Founded
  • MRUS 2003
  • NOV 1862
  • Country
  • MRUS Netherlands
  • NOV United States
  • Employees
  • MRUS N/A
  • NOV N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • NOV Metal Fabrications
  • Sector
  • MRUS Health Care
  • NOV Industrials
  • Exchange
  • MRUS Nasdaq
  • NOV Nasdaq
  • Market Cap
  • MRUS 5.1B
  • NOV 4.9B
  • IPO Year
  • MRUS 2016
  • NOV 1996
  • Fundamental
  • Price
  • MRUS $94.38
  • NOV $13.18
  • Analyst Decision
  • MRUS Buy
  • NOV Buy
  • Analyst Count
  • MRUS 18
  • NOV 17
  • Target Price
  • MRUS $93.72
  • NOV $16.41
  • AVG Volume (30 Days)
  • MRUS 4.2M
  • NOV 3.8M
  • Earning Date
  • MRUS 10-30-2025
  • NOV 10-27-2025
  • Dividend Yield
  • MRUS N/A
  • NOV 2.20%
  • EPS Growth
  • MRUS N/A
  • NOV N/A
  • EPS
  • MRUS N/A
  • NOV 1.21
  • Revenue
  • MRUS $56,228,000.00
  • NOV $8,790,000,000.00
  • Revenue This Year
  • MRUS $47.25
  • NOV N/A
  • Revenue Next Year
  • MRUS N/A
  • NOV $0.16
  • P/E Ratio
  • MRUS N/A
  • NOV $11.25
  • Revenue Growth
  • MRUS 59.77
  • NOV N/A
  • 52 Week Low
  • MRUS $33.19
  • NOV $10.84
  • 52 Week High
  • MRUS $94.56
  • NOV $16.86
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 86.13
  • NOV 50.03
  • Support Level
  • MRUS $66.13
  • NOV $13.17
  • Resistance Level
  • MRUS $94.45
  • NOV $13.91
  • Average True Range (ATR)
  • MRUS 1.00
  • NOV 0.40
  • MACD
  • MRUS 1.49
  • NOV 0.01
  • Stochastic Oscillator
  • MRUS 99.38
  • NOV 55.47

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: